US OptionsDetailed Quotes
AXDX241220P2500
- 1.05
- 0.000.00%
15min DelayClose Nov 22 16:00 ET
0.00High0.00Low
1.05Open1.05Pre Close0 Volume1 Open Interest2.50Strike Price0.00Turnover0.00%IV11.59%PremiumDec 20, 2024Expiry Date0.86Intrinsic Value100Multiplier26DDays to Expiry0.19Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.12Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Accelerate Diagnostics Stock Discussion
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
An automated platform designed to fight against Sepsis and Antimicrobial Resistance (AMR)
Enables rapid, automated microbial identification on the Bruker MALDI Biotyper® CA System directly from positive blood culture samples
TUCSON, Ariz., Sept. 30, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S....
$Borealis Foods Inc. (BRLS)$: +98.75%.
$Snap Inc. (SNAP)$: Notable increase following positive news and potential regulatory changes.
$Mullen Automotive Inc. (MULN)$: Volatile with low float, ideal for day traders.
$TransCode Therapeutics, Inc. (RNAZ)$: +55.65% due to advances in biotechnology.
$Akso Health Group (AHG)$: +67.14%, with growth in the health sector.
$Accelerate Diagnostics, Inc. (AXDX)$: +56.46%, momentum in medical diagnostics.
$Bakkt Holdings, Inc. (B...
No comment yet